Why the Mayne Pharma Group Ltd (ASX:MYX) share price has sunk lower today

The Mayne Pharma Group Ltd (ASX:MYX) share price has sunk lower on the day of its AGM despite revealing an impressive start to the year…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Mayne Pharma Group Ltd (ASX: MYX) share price has certainly had an eventful day.

At the time of writing the pharmaceutical company's shares are down almost 6% to 98 cents, whereas in early trade its shares were up as much 5%.

What happened?

This morning Mayne Pharma is holding its annual general meeting. Ahead of the event the company released its annual general meeting speeches to the market which included an update for the first four months of FY 2019.

According to the release, Mayne Pharma has had a positive start to FY 2019. Group revenue at the end of October was up 21% on the prior corresponding period to $183 million. This was driven by growth in all four of its operating segments.

Pleasingly, the company's gross profit has grown at even quicker rate. During the four months it achieved a 75% increase in gross profit compared to the prior corresponding period to $108 million.

Mayne Pharma saw its gross profit margin lift to 59% during the period thanks to a greater contribution from its high margin Specialty Brands segment, cost savings from bringing manufacturing in-house, favourable product sales mix in generics, and normalised levels of stock obsolescence and Doryx returns.

So why are its shares sinking lower?

Mayne Pharma has undoubtedly had a strong start to FY 2019. However, neither the CEO nor the chairman provided any comments on expectations for the full year.

As a result, I suspect that the lack of any guidance has spooked investors and sent some to the exits.

Should you buy the dip?

If the company can continue this form through to the second half of FY 2019 then I think Mayne Pharma's shares could prove to be a great investment option.

However, it might be worth holding out until the release of its half year results early next year to see if this level of performance has been sustained.

In the meantime, I think CSL Limited (ASX: CSL) and Telix Pharmaceuticals Ltd (ASX: TLX) could be worth a closer look.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why 4DS, Lynas, REA Group, and Rio Tinto shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Computershare, Ora Banda, Origin Energy, and Vulcan shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

Why did this $1.4 billion ASX 200 healthcare stock just dive 9%?

The market didn't like what this stock had to say this morning...

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why CAR Group, Myer, Neuren, and Yancoal shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

A male lion with a large mane sits atop a rocky mountain outcrop surveying the view, representing the outlook for the Liontown share price in FY23
Materials Shares

Liontown shares crashed 68% in 2024. Here's why

Investors sent Liontown shares tumbling in 2024.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Mesoblast, Myer, Premier Investments, and Vulcan shares are falling today

These shares are having a tough session on Tuesday. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Alkane, Myer, Premier Investments, and St Barbara shares are sinking today

These shares are having a poor start to the week. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Bank Shares

Why is the Westpac share price being hit so hard today?

The bank is currently the worst-performing member of the big four.

Read more »